Skip to content

ATRICURE INC (ATRC) — insider trading

Health Care · NASDAQ

ATRICURE INC (ATRC) has 29 reported SEC Form 4 insider transactions in our data, including 12 open-market sales among the most recent 29 (latest 2026-09-23).

Recent Form 4 transactions

DateInsiderRoleTypeSharesPriceValueFiling
2026-09-23 Privitera Salvatore Officer (Chief Technical Officer) Open-market sale 4,519 $60.00 $271.1K Form 4
2026-09-11 GROVES REGINA E Director Open-market sale 5,313 $54.22 $288.1K Form 4
2026-09-08 Privitera Salvatore Officer (Chief Technical Officer) Open-market sale 3,657 $55.00 $201.1K Form 4
2026-09-02 Privitera Salvatore Officer (Chief Technical Officer) Open-market sale 7,763 $52.50 $407.6K Form 4
2026-08-24 Dahlquist Karl S. Officer (Chief Legal Officer) Open-market sale 9,370 $48.89 $458.1K Form 4
2026-08-05 Yuen Maggie Director Open-market sale 3,500 $38.42 $134.5K Form 4
2026-08-05 Prange Karen Director Open-market sale 3,564 $38.80 $138.3K Form 4
2026-07-30 CARREL MICHAEL H Director, Officer (President, CEO, & Director) Bona fide gift 4,000 — $0 Form 4
2026-07-30 CARREL MICHAEL H Director, Officer (President, CEO, & Director) Bona fide gift 700 — $0 Form 4
2026-07-29 Noznesky Justin J Officer (Chief Mktg & Strategy Officer) Open-market sale 6,182 $38.80 $239.9K Form 4
2026-07-28 WEHRWEIN SVEN Director Option exercise / conversion (derivative) 25,000 — $0 Form 4
2026-07-28 WEHRWEIN SVEN Director Open-market sale 25,000 $37.84 $946.0K Form 4
2026-07-28 WEHRWEIN SVEN Director Option exercise / conversion 25,000 $19.95 $498.8K Form 4
2026-07-28 Doraiswamy Vinayak Officer (Chief Scientific Officer) Open-market sale 6,000 $38.88 $233.3K Form 4
2026-06-30 Privitera Salvatore Officer (Chief Technical Officer) Grant / award / vesting 636 $23.78 $15.1K Form 4
2026-06-30 Seith Douglas J Officer (Chief Operating Officer) Grant / award / vesting 527 $23.78 $12.5K Form 4
2026-06-30 Dahlquist Karl S. Officer (Chief Legal Officer) Grant / award / vesting 636 $23.78 $15.1K Form 4
2026-06-30 Doraiswamy Vinayak Officer (Chief Scientific Officer) Grant / award / vesting 636 $23.78 $15.1K Form 4
2026-06-30 CARREL MICHAEL H Director, Officer (President, CEO, & Director) Grant / award / vesting 636 $23.78 $15.1K Form 4
2026-05-20 Prange Karen Director Open-market sale 3,000 $28.65 $86.0K Form 4
2026-05-18 WHITE ROBERT S. Director Grant / award / vesting 6,144 — $0 Form 4
2026-05-18 WEHRWEIN SVEN Director Grant / award / vesting 6,144 — $0 Form 4
2026-05-18 GROVES REGINA E Director Grant / award / vesting 6,144 — $0 Form 4
2026-05-18 JOHNSON B KRISTINE Director Grant / award / vesting 6,144 — $0 Form 4
2026-05-18 Nachman Shlomo Director Grant / award / vesting 6,144 — $0 Form 4
2026-05-18 Yuen Maggie Director Grant / award / vesting 6,144 — $0 Form 4
2026-05-18 Telman Deborah H Director Grant / award / vesting 6,144 — $0 Form 4
2026-05-18 Prange Karen Director Grant / award / vesting 6,144 — $0 Form 4
2026-05-15 Doraiswamy Vinayak Officer (Chief Scientific Officer) Open-market sale 5,000 $28.13 $140.7K Form 4

Ask the chat about ATRC's insider activity →

Transaction types are the SEC Form 4 codes: open-market purchases (P) and sales (S) are the only rows that reflect open-market conviction. Awards/vesting (A), option exercises (M/X/C), shares withheld for taxes (F) and gifts (G) are compensation or mechanical, not buying or selling on the open market. Sales may be planned and non-discretionary (e.g. a Rule 10b5-1 plan); open-market buying is not a recommendation to buy. Informational only — not financial advice.

Source: SEC EDGAR Form 3/4/5. See the full company profile: ATRICURE INC (ATRC).

Last updated 2026-09-23 (most recent filing date).

Informational only — NOT financial advice. Insider filings are sourced from SEC EDGAR and shown with their reported dates.